In future, patient involvement and the patients’ “voice” will have an increasingly important role.
We were particularly thanked for service-mindedness and meeting the agreed timelines as well as for co-operation fostering our clients’ business goals.
This year we made a donation to the Finnish Association for Nature Conservation in their climate protection work.
Co-operation can produce high-quality and topical scientific reports, transparent processes and clear requirements for the evidence required.
Join us in Copenhagen on 2-6 November 2019! Drop by booth #C2-011 and have a chat with us.
Is Europe prepared to assess medicines based on new technologies or novel innovations, or different types of study data?
Meet us at the TOPRA Annual Symposium on 30 September – 2 October 2019 in Dublin, Ireland.
EMA has published guidance to marketing authorisation holders and authorities to improve and harmonise management of medicine shortages and related reporting and communication.
The expert event brought together more than 50 representatives of the pharma industry and medicinal wholesalers to exchange experiences and thoughts on how to control availability of medicines.
Pauliina Lajunen will help boost DRA’s growth and internationalization with her business and marketing expertise. Welcome Pauliina!
Availability of risk management materials and electronic systems were much-discussed topics at the traditional pharmacovigilance seminar in Oslo.